MONTREAL, March 8, 2005 (PRIMEZONE) -- Viropro Pharma Inc., a subsidiary of Viropro, Inc. (OTCBB:VPRO), announced the addition of a new line of natural consumer products under the leadership of Mr. Prosper Azoulay.
This line consists primarily of exclusive natural and homeopathic health products with many of the ingredients or formulations sourced in Europe and Brazil. These products complement Viropro Pharma's other biopharmaceutical products and its overall business direction.
"The introduction of this new line of natural products and ingredients evolved from global trends and the noticeable increase in consumer interest and demand for these types of products," said Mr. Richard Lee, President of Viropro. "These products should find their way into the national and international market place through our field agents and expanding distribution networks. The commercialization phase of this business line is scheduled for April, 2005, rapidly generating substantial revenues and profitability in the months to follow."
Viropro Pharma is proud to welcome Mr. Azoulay to its management team to steer this new business. His primary mandate is to ensure the line's profitability in North America, Brazil and Southeast Asia, while developing strategic alliances with distributors aimed at the exclusive acquisition of new lines of natural consumer and health products.
Mr. Azoulay brings with him over 25 years of experience to Viropro Pharma in creating, launching and commercialising prestigious consumer product lines in North America. Mr. Azoulay has been successful in opening retail stores and franchising concepts.
About Viropro Inc.
Viropro, Inc. (OTCBB:VPRO) is establishing a growth portfolio in Life Sciences markets through strategic alliances and revenue-producing acquisitions with the potential for continued shareholder value.
Viropro, Inc.'s Safe Harbor Statement
Except for any historic information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, which are subject to section 27A of the Securities Act of 1933 and section 21E of the Exchange Act of 1934, and are subject to safe harbor created by these sections. Any statements that express or involve discussions with respect to predictions, beliefs, plans, projections, objectives, goals, assumptions of future events or performances are not statements of historical fact and may be "forward looking statements". Forward looking statements in this release may be identified through the use of such words as "expects", "anticipates", "estimates", "believes", or statements indicating certain actions "may", "could", or "might" occur. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements, which involve numerous risks and uncertainties, including the Company's ability to market its products and services in a competitive environment as well as other factors.
Direct All Inquiries To Trivor Financial Communications.